Guanine nucleotides inhibit binding of agonists and antagonists to soluble opiate receptors.
The guanine nucleotides GDP, GTP, and guanosine-5'-(beta, gamma-imido)triphosphate inhibit binding of opiates and opioid peptides to receptors solubilized from membranes of neuroblastoma X glioma NG108-15 hybrid cells. The inhibition reflects decreased affinity of receptors for opioid ligands. Whereas in membranes, only opioid agonist binding is sensitive to guanine nucleotide inhibition, both agonist and antagonist binding is reduced in the case of soluble receptors. Furthermore, soluble receptors are more sensitive to the effects of guanine nucleotides than are membrane-bound receptors. These observations are consistent with the suggestion that solubilized receptors may be complexes of an opiate binding protein and a guanine nucleotide-sensitive regulatory component.
D000818:Animals; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D004174:Diprenorphine / Q000378:metabolism*; D005048:Etorphine / Q000378:metabolism*; D005910:Glioma; D006150:Guanine Nucleotides / Q000494:pharmacology*; D006153:Guanosine Diphosphate / Q000494:pharmacology; D006160:Guanosine Triphosphate / Q000494:pharmacology; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D006822:Hybrid Cells / Q000378:metabolism; D007700:Kinetics; D051379:Mice; D009019:Morphinans / Q000378:metabolism*; D009447:Neuroblastoma; D051381:Rats; D011957:Receptors, Opioid / Q000187:drug effects / Q000378:metabolism*
D006150:Guanine Nucleotides; D009019:Morphinans; D011957:Receptors, Opioid; D006153:Guanosine Diphosphate; D004174:Diprenorphine; D006165:Guanylyl Imidodiphosphate; D005048:Etorphine; D006160:Guanosine Triphosphate